Rayls (RLS) fluctuated by 46.2% in 24 hours: trading volume surged 251% and CEX net outflows triggered speculative volatility
Bitget Pulse2026/04/18 21:07Volatility Brief
In the past 24 hours, the price of RLS rebounded from a low of $0.00275 to a high of $0.00402, currently trading at $0.00366, with a fluctuation amplitude of 46.2%. Trading volume has increased significantly, with 24-hour spot trading volume ranging from approximately $2.35 million to $8.66 million, a surge of 251% compared to the previous day. In terms of funds, CEX saw a net outflow, amplifying market volatility.
Analysis of the Cause of the Abnormal Movement
- Trading volume skyrocketed by 251%, driving rapid price increases and pullbacks, resulting in a highly volatile environment.
- Significant net outflow from CEX, with funds shifting to on-chain or DEX, triggering speculative buying and selling, directly magnifying price swings.
No official announcements or major on-chain events have been reported; the abnormal movement is mainly driven by market speculation.
Market Views and Outlook
Market sentiment is slightly optimistic in the short term, with overall price increase of about 20%-24% in 24 hours and improved trading activity. However, technical analysis shows a key support level near $0.0027; if this fails, bearish sentiment may prevail. Community discussions focus on support/resistance level trading. Analysts warn of risks associated with thin liquidity and susceptibility to large trade impact. In the short term, volatility may continue; watch for price breakthroughs above $0.0035.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Core business achieves fastest growth in over a decade! Gilead (GILD.US) Q3 is a mix of good and bad news: Raises full-year sales guidance but Biktarvy will face a 38% price cut pressure from U.S. Medicare
On October 29th (Thursday) local time, US biopharmaceutical giant Gilead Sciences (GILD.US) released its financial report for the third quarter of 2026. Driven by double-digit growth in its flagship HIV drug portfolio, the company's product sales in the quarter increased by 13% year-over-year to $8.3 billion, surpassing market expectations.
Bank of Japan to leave interest rates steady at 1.25%
U.S. mortgage rates fall for two consecutive weeks but struggle to boost market; home sales prices decline for the first time in over three years
U.S. mortgage rates have declined for the second consecutive week but remain above 7%, failing to effectively boost the persistently sluggish housing market.
SpaceX's largest single customer revealed: Anthropic pays over $3 billion per month, accounting for more than one-third of Q3 revenue
According to media reports, Anthropic is currently SpaceX's largest single customer, contributing 34.5% of SpaceX's revenue in the third quarter of this year. This exposure has raised market concerns about the stability of SpaceX's revenue, as Anthropic could exercise its contract exit rights as early as next year. Elon Musk predicts that NASA payments will account for less than 5% of the company's revenue by 2026.
Crypto prices
More
